nodes	percent_of_prediction	percent_of_DWPC	metapath
Nicardipine—ABCB1—peripheral nervous system neoplasm	0.239	1	CbGaD
Nicardipine—CYP2B6—Tretinoin—peripheral nervous system neoplasm	0.0454	0.102	CbGbCtD
Nicardipine—CYP2E1—Dacarbazine—peripheral nervous system neoplasm	0.0395	0.0893	CbGbCtD
Nicardipine—CYP3A5—Tretinoin—peripheral nervous system neoplasm	0.0357	0.0807	CbGbCtD
Nicardipine—CYP2C8—Tretinoin—peripheral nervous system neoplasm	0.0344	0.0776	CbGbCtD
Nicardipine—ABCB1—Alitretinoin—peripheral nervous system neoplasm	0.025	0.0565	CbGbCtD
Nicardipine—ABCB1—Topotecan—peripheral nervous system neoplasm	0.025	0.0565	CbGbCtD
Nicardipine—CYP2C9—Tretinoin—peripheral nervous system neoplasm	0.024	0.0541	CbGbCtD
Nicardipine—CYP2B6—Cisplatin—peripheral nervous system neoplasm	0.0194	0.0439	CbGbCtD
Nicardipine—CYP2E1—Etoposide—peripheral nervous system neoplasm	0.0193	0.0437	CbGbCtD
Nicardipine—ABCB1—Dactinomycin—peripheral nervous system neoplasm	0.0173	0.0392	CbGbCtD
Nicardipine—CYP3A5—Vincristine—peripheral nervous system neoplasm	0.0164	0.037	CbGbCtD
Nicardipine—CYP3A5—Etoposide—peripheral nervous system neoplasm	0.015	0.0339	CbGbCtD
Nicardipine—CYP3A4—Topotecan—peripheral nervous system neoplasm	0.015	0.0338	CbGbCtD
Nicardipine—CYP2C8—Etoposide—peripheral nervous system neoplasm	0.0145	0.0326	CbGbCtD
Nicardipine—CYP3A4—Tretinoin—peripheral nervous system neoplasm	0.0139	0.0315	CbGbCtD
Nicardipine—CYP2B6—Doxorubicin—peripheral nervous system neoplasm	0.013	0.0294	CbGbCtD
Nicardipine—ABCB1—Vincristine—peripheral nervous system neoplasm	0.0107	0.0241	CbGbCtD
Nicardipine—CYP2C9—Cisplatin—peripheral nervous system neoplasm	0.0103	0.0232	CbGbCtD
Nicardipine—ABCB1—Cisplatin—peripheral nervous system neoplasm	0.00996	0.0225	CbGbCtD
Nicardipine—ABCB1—Etoposide—peripheral nervous system neoplasm	0.00978	0.0221	CbGbCtD
Nicardipine—CACNA1D—cochlear duct of membranous labyrinth—peripheral nervous system neoplasm	0.0096	0.207	CbGeAlD
Nicardipine—ABCB1—Doxorubicin—peripheral nervous system neoplasm	0.00667	0.0151	CbGbCtD
Nicardipine—CYP3A4—Vincristine—peripheral nervous system neoplasm	0.0064	0.0144	CbGbCtD
Nicardipine—CYP2D6—Doxorubicin—peripheral nervous system neoplasm	0.00629	0.0142	CbGbCtD
Nicardipine—CYP3A4—Etoposide—peripheral nervous system neoplasm	0.00586	0.0132	CbGbCtD
Nicardipine—CACNA1D—cochlea—peripheral nervous system neoplasm	0.00486	0.105	CbGeAlD
Nicardipine—CACNA1D—internal ear—peripheral nervous system neoplasm	0.00461	0.0993	CbGeAlD
Nicardipine—CYP3A4—Doxorubicin—peripheral nervous system neoplasm	0.004	0.00903	CbGbCtD
Nicardipine—CALM1—trigeminal nerve—peripheral nervous system neoplasm	0.00324	0.0697	CbGeAlD
Nicardipine—CALM1—cranial nerve—peripheral nervous system neoplasm	0.00231	0.0497	CbGeAlD
Nicardipine—CALM2—pons—peripheral nervous system neoplasm	0.00229	0.0493	CbGeAlD
Nicardipine—CALM1—pons—peripheral nervous system neoplasm	0.00228	0.0491	CbGeAlD
Nicardipine—PDE1A—brainstem—peripheral nervous system neoplasm	0.0013	0.0281	CbGeAlD
Nicardipine—CALM2—nerve—peripheral nervous system neoplasm	0.00119	0.0256	CbGeAlD
Nicardipine—CALM1—nerve—peripheral nervous system neoplasm	0.00118	0.0255	CbGeAlD
Nicardipine—CALM2—ganglion—peripheral nervous system neoplasm	0.00117	0.0253	CbGeAlD
Nicardipine—CALM1—ganglion—peripheral nervous system neoplasm	0.00117	0.0251	CbGeAlD
Nicardipine—Clevidipine—BCHE—peripheral nervous system neoplasm	0.00106	0.388	CrCbGaD
Nicardipine—CACNA2D1—brainstem—peripheral nervous system neoplasm	0.000902	0.0194	CbGeAlD
Nicardipine—PDE1B—cerebellum—peripheral nervous system neoplasm	0.000766	0.0165	CbGeAlD
Nicardipine—CALM3—trigeminal ganglion—peripheral nervous system neoplasm	0.000733	0.0158	CbGeAlD
Nicardipine—CALM3—parotid gland—peripheral nervous system neoplasm	0.000692	0.0149	CbGeAlD
Nicardipine—PDE1A—cerebellum—peripheral nervous system neoplasm	0.000642	0.0138	CbGeAlD
Nicardipine—CHRM1—parotid gland—peripheral nervous system neoplasm	0.00062	0.0134	CbGeAlD
Nicardipine—CALM2—trigeminal ganglion—peripheral nervous system neoplasm	0.000576	0.0124	CbGeAlD
Nicardipine—CALM1—trigeminal ganglion—peripheral nervous system neoplasm	0.000573	0.0123	CbGeAlD
Nicardipine—CALM2—parotid gland—peripheral nervous system neoplasm	0.000543	0.0117	CbGeAlD
Nicardipine—CALM2—brainstem—peripheral nervous system neoplasm	0.00051	0.011	CbGeAlD
Nicardipine—CALM1—brainstem—peripheral nervous system neoplasm	0.000507	0.0109	CbGeAlD
Nicardipine—ADRA1A—brainstem—peripheral nervous system neoplasm	0.000478	0.0103	CbGeAlD
Nicardipine—CACNB2—cerebellum—peripheral nervous system neoplasm	0.000473	0.0102	CbGeAlD
Nicardipine—CACNA2D1—cerebellum—peripheral nervous system neoplasm	0.000445	0.00958	CbGeAlD
Nicardipine—CACNA1D—cerebellum—peripheral nervous system neoplasm	0.000414	0.00891	CbGeAlD
Nicardipine—Nisoldipine—ABCB1—peripheral nervous system neoplasm	0.000399	0.146	CrCbGaD
Nicardipine—CACNA1C—cerebellum—peripheral nervous system neoplasm	0.000382	0.00823	CbGeAlD
Nicardipine—Nitrendipine—ABCB1—peripheral nervous system neoplasm	0.000373	0.136	CrCbGaD
Nicardipine—Amlodipine—ABCB1—peripheral nervous system neoplasm	0.000321	0.117	CrCbGaD
Nicardipine—CALM3—cerebellum—peripheral nervous system neoplasm	0.00032	0.00689	CbGeAlD
Nicardipine—Felodipine—ABCB1—peripheral nervous system neoplasm	0.000297	0.108	CrCbGaD
Nicardipine—Nifedipine—ABCB1—peripheral nervous system neoplasm	0.000287	0.105	CrCbGaD
Nicardipine—CYP2D6—brainstem—peripheral nervous system neoplasm	0.000282	0.00606	CbGeAlD
Nicardipine—CALM2—cerebellum—peripheral nervous system neoplasm	0.000251	0.00541	CbGeAlD
Nicardipine—CALM1—cerebellum—peripheral nervous system neoplasm	0.00025	0.00539	CbGeAlD
Nicardipine—Insomnia—Alitretinoin—peripheral nervous system neoplasm	0.000241	0.00152	CcSEcCtD
Nicardipine—Diarrhoea—Tretinoin—peripheral nervous system neoplasm	0.000241	0.00152	CcSEcCtD
Nicardipine—Diarrhoea—Isotretinoin—peripheral nervous system neoplasm	0.000241	0.00152	CcSEcCtD
Nicardipine—Hypotension—Vincristine—peripheral nervous system neoplasm	0.00024	0.00152	CcSEcCtD
Nicardipine—Paraesthesia—Alitretinoin—peripheral nervous system neoplasm	0.000239	0.00151	CcSEcCtD
Nicardipine—Dyspnoea—Alitretinoin—peripheral nervous system neoplasm	0.000238	0.0015	CcSEcCtD
Nicardipine—Diarrhoea—Melphalan—peripheral nervous system neoplasm	0.000237	0.0015	CcSEcCtD
Nicardipine—Somnolence—Alitretinoin—peripheral nervous system neoplasm	0.000237	0.0015	CcSEcCtD
Nicardipine—Myalgia—Cisplatin—peripheral nervous system neoplasm	0.000237	0.0015	CcSEcCtD
Nicardipine—Feeling abnormal—Dactinomycin—peripheral nervous system neoplasm	0.000237	0.0015	CcSEcCtD
Nicardipine—Ill-defined disorder—Etoposide—peripheral nervous system neoplasm	0.000236	0.0015	CcSEcCtD
Nicardipine—Anxiety—Cisplatin—peripheral nervous system neoplasm	0.000236	0.00149	CcSEcCtD
Nicardipine—ADRA1A—cerebellum—peripheral nervous system neoplasm	0.000236	0.00508	CbGeAlD
Nicardipine—Gastrointestinal pain—Dactinomycin—peripheral nervous system neoplasm	0.000235	0.00149	CcSEcCtD
Nicardipine—Hot flush—Doxorubicin—peripheral nervous system neoplasm	0.000235	0.00148	CcSEcCtD
Nicardipine—Dyspepsia—Alitretinoin—peripheral nervous system neoplasm	0.000235	0.00148	CcSEcCtD
Nicardipine—Dizziness—Topotecan—peripheral nervous system neoplasm	0.000234	0.00148	CcSEcCtD
Nicardipine—Discomfort—Cisplatin—peripheral nervous system neoplasm	0.000234	0.00148	CcSEcCtD
Nicardipine—Musculoskeletal discomfort—Vincristine—peripheral nervous system neoplasm	0.000234	0.00148	CcSEcCtD
Nicardipine—Menopausal symptoms—Doxorubicin—peripheral nervous system neoplasm	0.000233	0.00147	CcSEcCtD
Nicardipine—Dizziness—Tretinoin—peripheral nervous system neoplasm	0.000232	0.00147	CcSEcCtD
Nicardipine—Dizziness—Isotretinoin—peripheral nervous system neoplasm	0.000232	0.00147	CcSEcCtD
Nicardipine—Insomnia—Vincristine—peripheral nervous system neoplasm	0.000232	0.00147	CcSEcCtD
Nicardipine—Paraesthesia—Vincristine—peripheral nervous system neoplasm	0.000231	0.00146	CcSEcCtD
Nicardipine—Malaise—Etoposide—peripheral nervous system neoplasm	0.00023	0.00145	CcSEcCtD
Nicardipine—Face oedema—Epirubicin—peripheral nervous system neoplasm	0.000229	0.00145	CcSEcCtD
Nicardipine—Vertigo—Etoposide—peripheral nervous system neoplasm	0.000229	0.00145	CcSEcCtD
Nicardipine—ABCB1—trigeminal ganglion—peripheral nervous system neoplasm	0.000229	0.00493	CbGeAlD
Nicardipine—Pain—Alitretinoin—peripheral nervous system neoplasm	0.000228	0.00144	CcSEcCtD
Nicardipine—Constipation—Alitretinoin—peripheral nervous system neoplasm	0.000228	0.00144	CcSEcCtD
Nicardipine—Abdominal pain—Dactinomycin—peripheral nervous system neoplasm	0.000227	0.00144	CcSEcCtD
Nicardipine—Body temperature increased—Dactinomycin—peripheral nervous system neoplasm	0.000227	0.00144	CcSEcCtD
Nicardipine—Oedema—Cisplatin—peripheral nervous system neoplasm	0.000227	0.00144	CcSEcCtD
Nicardipine—Infection—Cisplatin—peripheral nervous system neoplasm	0.000226	0.00143	CcSEcCtD
Nicardipine—Vomiting—Topotecan—peripheral nervous system neoplasm	0.000225	0.00143	CcSEcCtD
Nicardipine—Loss of consciousness—Etoposide—peripheral nervous system neoplasm	0.000224	0.00142	CcSEcCtD
Nicardipine—Vomiting—Tretinoin—peripheral nervous system neoplasm	0.000224	0.00141	CcSEcCtD
Nicardipine—Vomiting—Isotretinoin—peripheral nervous system neoplasm	0.000224	0.00141	CcSEcCtD
Nicardipine—Rash—Topotecan—peripheral nervous system neoplasm	0.000223	0.00141	CcSEcCtD
Nicardipine—Dermatitis—Topotecan—peripheral nervous system neoplasm	0.000223	0.00141	CcSEcCtD
Nicardipine—Thrombocytopenia—Cisplatin—peripheral nervous system neoplasm	0.000222	0.00141	CcSEcCtD
Nicardipine—Headache—Topotecan—peripheral nervous system neoplasm	0.000222	0.0014	CcSEcCtD
Nicardipine—Rash—Tretinoin—peripheral nervous system neoplasm	0.000222	0.0014	CcSEcCtD
Nicardipine—Rash—Isotretinoin—peripheral nervous system neoplasm	0.000222	0.0014	CcSEcCtD
Nicardipine—Tachycardia—Cisplatin—peripheral nervous system neoplasm	0.000222	0.0014	CcSEcCtD
Nicardipine—Dermatitis—Isotretinoin—peripheral nervous system neoplasm	0.000221	0.0014	CcSEcCtD
Nicardipine—Dermatitis—Tretinoin—peripheral nervous system neoplasm	0.000221	0.0014	CcSEcCtD
Nicardipine—Vomiting—Melphalan—peripheral nervous system neoplasm	0.000221	0.0014	CcSEcCtD
Nicardipine—Headache—Tretinoin—peripheral nervous system neoplasm	0.00022	0.00139	CcSEcCtD
Nicardipine—Headache—Isotretinoin—peripheral nervous system neoplasm	0.00022	0.00139	CcSEcCtD
Nicardipine—Hypertension—Etoposide—peripheral nervous system neoplasm	0.00022	0.00139	CcSEcCtD
Nicardipine—Feeling abnormal—Alitretinoin—peripheral nervous system neoplasm	0.00022	0.00139	CcSEcCtD
Nicardipine—Constipation—Vincristine—peripheral nervous system neoplasm	0.00022	0.00139	CcSEcCtD
Nicardipine—Pain—Vincristine—peripheral nervous system neoplasm	0.00022	0.00139	CcSEcCtD
Nicardipine—Hyperhidrosis—Cisplatin—peripheral nervous system neoplasm	0.000219	0.00139	CcSEcCtD
Nicardipine—Rash—Melphalan—peripheral nervous system neoplasm	0.000219	0.00138	CcSEcCtD
Nicardipine—Dermatitis—Melphalan—peripheral nervous system neoplasm	0.000219	0.00138	CcSEcCtD
Nicardipine—Gastrointestinal pain—Alitretinoin—peripheral nervous system neoplasm	0.000218	0.00138	CcSEcCtD
Nicardipine—Chest pain—Etoposide—peripheral nervous system neoplasm	0.000217	0.00137	CcSEcCtD
Nicardipine—Orthostatic hypotension—Epirubicin—peripheral nervous system neoplasm	0.000217	0.00137	CcSEcCtD
Nicardipine—Hypokalaemia—Epirubicin—peripheral nervous system neoplasm	0.000216	0.00137	CcSEcCtD
Nicardipine—Discomfort—Etoposide—peripheral nervous system neoplasm	0.000214	0.00136	CcSEcCtD
Nicardipine—Hypotension—Cisplatin—peripheral nervous system neoplasm	0.000212	0.00134	CcSEcCtD
Nicardipine—Face oedema—Doxorubicin—peripheral nervous system neoplasm	0.000212	0.00134	CcSEcCtD
Nicardipine—Hypersensitivity—Dactinomycin—peripheral nervous system neoplasm	0.000212	0.00134	CcSEcCtD
Nicardipine—Body temperature increased—Alitretinoin—peripheral nervous system neoplasm	0.000211	0.00133	CcSEcCtD
Nicardipine—Abdominal pain—Alitretinoin—peripheral nervous system neoplasm	0.000211	0.00133	CcSEcCtD
Nicardipine—Nausea—Topotecan—peripheral nervous system neoplasm	0.000211	0.00133	CcSEcCtD
Nicardipine—Gastrointestinal pain—Vincristine—peripheral nervous system neoplasm	0.00021	0.00133	CcSEcCtD
Nicardipine—Confusional state—Etoposide—peripheral nervous system neoplasm	0.00021	0.00133	CcSEcCtD
Nicardipine—Nausea—Tretinoin—peripheral nervous system neoplasm	0.000209	0.00132	CcSEcCtD
Nicardipine—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.000209	0.00132	CcSEcCtD
Nicardipine—Musculoskeletal discomfort—Cisplatin—peripheral nervous system neoplasm	0.000207	0.00131	CcSEcCtD
Nicardipine—Infection—Etoposide—peripheral nervous system neoplasm	0.000207	0.00131	CcSEcCtD
Nicardipine—Asthenia—Dactinomycin—peripheral nervous system neoplasm	0.000206	0.0013	CcSEcCtD
Nicardipine—Nausea—Melphalan—peripheral nervous system neoplasm	0.000206	0.0013	CcSEcCtD
Nicardipine—Paraesthesia—Cisplatin—peripheral nervous system neoplasm	0.000204	0.00129	CcSEcCtD
Nicardipine—Thrombocytopenia—Etoposide—peripheral nervous system neoplasm	0.000204	0.00129	CcSEcCtD
Nicardipine—Tachycardia—Etoposide—peripheral nervous system neoplasm	0.000203	0.00128	CcSEcCtD
Nicardipine—Body temperature increased—Vincristine—peripheral nervous system neoplasm	0.000203	0.00128	CcSEcCtD
Nicardipine—Abdominal pain—Vincristine—peripheral nervous system neoplasm	0.000203	0.00128	CcSEcCtD
Nicardipine—Dyspnoea—Cisplatin—peripheral nervous system neoplasm	0.000202	0.00128	CcSEcCtD
Nicardipine—Hyperhidrosis—Etoposide—peripheral nervous system neoplasm	0.000201	0.00127	CcSEcCtD
Nicardipine—Orthostatic hypotension—Doxorubicin—peripheral nervous system neoplasm	0.0002	0.00127	CcSEcCtD
Nicardipine—Hypokalaemia—Doxorubicin—peripheral nervous system neoplasm	0.0002	0.00126	CcSEcCtD
Nicardipine—Angina pectoris—Epirubicin—peripheral nervous system neoplasm	0.0002	0.00126	CcSEcCtD
Nicardipine—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	0.000197	0.00124	CcSEcCtD
Nicardipine—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	0.000196	0.00124	CcSEcCtD
Nicardipine—Hypotension—Etoposide—peripheral nervous system neoplasm	0.000194	0.00123	CcSEcCtD
Nicardipine—Pain—Cisplatin—peripheral nervous system neoplasm	0.000194	0.00123	CcSEcCtD
Nicardipine—Asthenia—Alitretinoin—peripheral nervous system neoplasm	0.000191	0.00121	CcSEcCtD
Nicardipine—Pollakiuria—Epirubicin—peripheral nervous system neoplasm	0.000189	0.0012	CcSEcCtD
Nicardipine—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	0.000189	0.0012	CcSEcCtD
Nicardipine—Feeling abnormal—Cisplatin—peripheral nervous system neoplasm	0.000187	0.00118	CcSEcCtD
Nicardipine—Paraesthesia—Etoposide—peripheral nervous system neoplasm	0.000187	0.00118	CcSEcCtD
Nicardipine—Dyspnoea—Etoposide—peripheral nervous system neoplasm	0.000185	0.00117	CcSEcCtD
Nicardipine—Somnolence—Etoposide—peripheral nervous system neoplasm	0.000185	0.00117	CcSEcCtD
Nicardipine—Angina pectoris—Doxorubicin—peripheral nervous system neoplasm	0.000185	0.00117	CcSEcCtD
Nicardipine—Asthenia—Vincristine—peripheral nervous system neoplasm	0.000184	0.00116	CcSEcCtD
Nicardipine—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.000183	0.00116	CcSEcCtD
Nicardipine—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	0.000182	0.00115	CcSEcCtD
Nicardipine—Rash—Dactinomycin—peripheral nervous system neoplasm	0.000181	0.00115	CcSEcCtD
Nicardipine—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	0.000179	0.00113	CcSEcCtD
Nicardipine—Constipation—Etoposide—peripheral nervous system neoplasm	0.000178	0.00112	CcSEcCtD
Nicardipine—Pain—Etoposide—peripheral nervous system neoplasm	0.000178	0.00112	CcSEcCtD
Nicardipine—Conjunctivitis—Epirubicin—peripheral nervous system neoplasm	0.000178	0.00112	CcSEcCtD
Nicardipine—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.000176	0.00111	CcSEcCtD
Nicardipine—Diarrhoea—Vincristine—peripheral nervous system neoplasm	0.000176	0.00111	CcSEcCtD
Nicardipine—CYP2E1—cerebellum—peripheral nervous system neoplasm	0.000175	0.00378	CbGeAlD
Nicardipine—Sweating—Epirubicin—peripheral nervous system neoplasm	0.000175	0.00111	CcSEcCtD
Nicardipine—Pollakiuria—Doxorubicin—peripheral nervous system neoplasm	0.000175	0.00111	CcSEcCtD
Nicardipine—Haematuria—Epirubicin—peripheral nervous system neoplasm	0.000174	0.0011	CcSEcCtD
Nicardipine—Sinusitis—Epirubicin—peripheral nervous system neoplasm	0.000171	0.00108	CcSEcCtD
Nicardipine—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	0.000171	0.00108	CcSEcCtD
Nicardipine—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.000171	0.00108	CcSEcCtD
Nicardipine—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	0.00017	0.00108	CcSEcCtD
Nicardipine—Dizziness—Vincristine—peripheral nervous system neoplasm	0.00017	0.00107	CcSEcCtD
Nicardipine—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.000169	0.00107	CcSEcCtD
Nicardipine—Rash—Alitretinoin—peripheral nervous system neoplasm	0.000168	0.00106	CcSEcCtD
Nicardipine—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.000168	0.00106	CcSEcCtD
Nicardipine—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	0.000167	0.00106	CcSEcCtD
Nicardipine—Headache—Alitretinoin—peripheral nervous system neoplasm	0.000167	0.00106	CcSEcCtD
Nicardipine—Rhinitis—Epirubicin—peripheral nervous system neoplasm	0.000165	0.00104	CcSEcCtD
Nicardipine—Abdominal pain—Etoposide—peripheral nervous system neoplasm	0.000164	0.00104	CcSEcCtD
Nicardipine—Body temperature increased—Etoposide—peripheral nervous system neoplasm	0.000164	0.00104	CcSEcCtD
Nicardipine—Conjunctivitis—Doxorubicin—peripheral nervous system neoplasm	0.000164	0.00104	CcSEcCtD
Nicardipine—Hypoaesthesia—Epirubicin—peripheral nervous system neoplasm	0.000163	0.00103	CcSEcCtD
Nicardipine—Vomiting—Vincristine—peripheral nervous system neoplasm	0.000163	0.00103	CcSEcCtD
Nicardipine—Asthenia—Cisplatin—peripheral nervous system neoplasm	0.000163	0.00103	CcSEcCtD
Nicardipine—Sweating—Doxorubicin—peripheral nervous system neoplasm	0.000162	0.00103	CcSEcCtD
Nicardipine—Rash—Vincristine—peripheral nervous system neoplasm	0.000162	0.00102	CcSEcCtD
Nicardipine—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.000162	0.00102	CcSEcCtD
Nicardipine—Oedema peripheral—Epirubicin—peripheral nervous system neoplasm	0.000162	0.00102	CcSEcCtD
Nicardipine—Haematuria—Doxorubicin—peripheral nervous system neoplasm	0.000161	0.00102	CcSEcCtD
Nicardipine—Headache—Vincristine—peripheral nervous system neoplasm	0.000161	0.00102	CcSEcCtD
Nicardipine—Sinusitis—Doxorubicin—peripheral nervous system neoplasm	0.000159	0.001	CcSEcCtD
Nicardipine—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.000158	0.001	CcSEcCtD
Nicardipine—Visual impairment—Epirubicin—peripheral nervous system neoplasm	0.000158	0.001	CcSEcCtD
Nicardipine—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	0.000155	0.000982	CcSEcCtD
Nicardipine—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	0.000153	0.000969	CcSEcCtD
Nicardipine—Tinnitus—Epirubicin—peripheral nervous system neoplasm	0.000153	0.000968	CcSEcCtD
Nicardipine—Nausea—Vincristine—peripheral nervous system neoplasm	0.000152	0.000964	CcSEcCtD
Nicardipine—Flushing—Epirubicin—peripheral nervous system neoplasm	0.000152	0.000963	CcSEcCtD
Nicardipine—Rhinitis—Doxorubicin—peripheral nervous system neoplasm	0.000152	0.000963	CcSEcCtD
Nicardipine—Hypoaesthesia—Doxorubicin—peripheral nervous system neoplasm	0.000151	0.000955	CcSEcCtD
Nicardipine—Oedema peripheral—Doxorubicin—peripheral nervous system neoplasm	0.00015	0.000946	CcSEcCtD
Nicardipine—Asthenia—Etoposide—peripheral nervous system neoplasm	0.000149	0.000944	CcSEcCtD
Nicardipine—Visual impairment—Doxorubicin—peripheral nervous system neoplasm	0.000146	0.000925	CcSEcCtD
Nicardipine—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.000144	0.000913	CcSEcCtD
Nicardipine—Rash—Cisplatin—peripheral nervous system neoplasm	0.000143	0.000905	CcSEcCtD
Nicardipine—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.000143	0.000904	CcSEcCtD
Nicardipine—Diarrhoea—Etoposide—peripheral nervous system neoplasm	0.000142	0.0009	CcSEcCtD
Nicardipine—Tinnitus—Doxorubicin—peripheral nervous system neoplasm	0.000142	0.000895	CcSEcCtD
Nicardipine—Flushing—Doxorubicin—peripheral nervous system neoplasm	0.000141	0.000891	CcSEcCtD
Nicardipine—Tension—Epirubicin—peripheral nervous system neoplasm	0.00014	0.000887	CcSEcCtD
Nicardipine—CYP2D6—cerebellum—peripheral nervous system neoplasm	0.000139	0.00299	CbGeAlD
Nicardipine—Nervousness—Epirubicin—peripheral nervous system neoplasm	0.000139	0.000877	CcSEcCtD
Nicardipine—Dizziness—Etoposide—peripheral nervous system neoplasm	0.000138	0.00087	CcSEcCtD
Nicardipine—Nausea—Cisplatin—peripheral nervous system neoplasm	0.000135	0.000853	CcSEcCtD
Nicardipine—Vision blurred—Epirubicin—peripheral nervous system neoplasm	0.000135	0.000851	CcSEcCtD
Nicardipine—Ill-defined disorder—Epirubicin—peripheral nervous system neoplasm	0.000133	0.000838	CcSEcCtD
Nicardipine—Vomiting—Etoposide—peripheral nervous system neoplasm	0.000132	0.000836	CcSEcCtD
Nicardipine—Agitation—Epirubicin—peripheral nervous system neoplasm	0.000131	0.00083	CcSEcCtD
Nicardipine—Rash—Etoposide—peripheral nervous system neoplasm	0.000131	0.000829	CcSEcCtD
Nicardipine—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.000131	0.000829	CcSEcCtD
Nicardipine—Headache—Etoposide—peripheral nervous system neoplasm	0.00013	0.000824	CcSEcCtD
Nicardipine—Tension—Doxorubicin—peripheral nervous system neoplasm	0.00013	0.00082	CcSEcCtD
Nicardipine—Malaise—Epirubicin—peripheral nervous system neoplasm	0.000129	0.000815	CcSEcCtD
Nicardipine—Nervousness—Doxorubicin—peripheral nervous system neoplasm	0.000128	0.000812	CcSEcCtD
Nicardipine—Vertigo—Epirubicin—peripheral nervous system neoplasm	0.000128	0.000812	CcSEcCtD
Nicardipine—Syncope—Epirubicin—peripheral nervous system neoplasm	0.000128	0.00081	CcSEcCtD
Nicardipine—Palpitations—Epirubicin—peripheral nervous system neoplasm	0.000126	0.000798	CcSEcCtD
Nicardipine—Loss of consciousness—Epirubicin—peripheral nervous system neoplasm	0.000126	0.000794	CcSEcCtD
Nicardipine—Vision blurred—Doxorubicin—peripheral nervous system neoplasm	0.000125	0.000788	CcSEcCtD
Nicardipine—Nausea—Etoposide—peripheral nervous system neoplasm	0.000124	0.000781	CcSEcCtD
Nicardipine—Hypertension—Epirubicin—peripheral nervous system neoplasm	0.000123	0.00078	CcSEcCtD
Nicardipine—Ill-defined disorder—Doxorubicin—peripheral nervous system neoplasm	0.000123	0.000776	CcSEcCtD
Nicardipine—Arthralgia—Epirubicin—peripheral nervous system neoplasm	0.000122	0.000769	CcSEcCtD
Nicardipine—Chest pain—Epirubicin—peripheral nervous system neoplasm	0.000122	0.000769	CcSEcCtD
Nicardipine—Myalgia—Epirubicin—peripheral nervous system neoplasm	0.000122	0.000769	CcSEcCtD
Nicardipine—Agitation—Doxorubicin—peripheral nervous system neoplasm	0.000121	0.000768	CcSEcCtD
Nicardipine—Anxiety—Epirubicin—peripheral nervous system neoplasm	0.000121	0.000766	CcSEcCtD
Nicardipine—Discomfort—Epirubicin—peripheral nervous system neoplasm	0.00012	0.00076	CcSEcCtD
Nicardipine—Malaise—Doxorubicin—peripheral nervous system neoplasm	0.000119	0.000754	CcSEcCtD
Nicardipine—Dry mouth—Epirubicin—peripheral nervous system neoplasm	0.000119	0.000752	CcSEcCtD
Nicardipine—Vertigo—Doxorubicin—peripheral nervous system neoplasm	0.000119	0.000751	CcSEcCtD
Nicardipine—Syncope—Doxorubicin—peripheral nervous system neoplasm	0.000119	0.00075	CcSEcCtD
Nicardipine—Confusional state—Epirubicin—peripheral nervous system neoplasm	0.000118	0.000743	CcSEcCtD
Nicardipine—Palpitations—Doxorubicin—peripheral nervous system neoplasm	0.000117	0.000739	CcSEcCtD
Nicardipine—Oedema—Epirubicin—peripheral nervous system neoplasm	0.000117	0.000737	CcSEcCtD
Nicardipine—Loss of consciousness—Doxorubicin—peripheral nervous system neoplasm	0.000116	0.000735	CcSEcCtD
Nicardipine—Infection—Epirubicin—peripheral nervous system neoplasm	0.000116	0.000732	CcSEcCtD
Nicardipine—Shock—Epirubicin—peripheral nervous system neoplasm	0.000115	0.000725	CcSEcCtD
Nicardipine—Thrombocytopenia—Epirubicin—peripheral nervous system neoplasm	0.000114	0.000722	CcSEcCtD
Nicardipine—Hypertension—Doxorubicin—peripheral nervous system neoplasm	0.000114	0.000722	CcSEcCtD
Nicardipine—Tachycardia—Epirubicin—peripheral nervous system neoplasm	0.000114	0.00072	CcSEcCtD
Nicardipine—Hyperhidrosis—Epirubicin—peripheral nervous system neoplasm	0.000113	0.000713	CcSEcCtD
Nicardipine—Myalgia—Doxorubicin—peripheral nervous system neoplasm	0.000113	0.000712	CcSEcCtD
Nicardipine—Arthralgia—Doxorubicin—peripheral nervous system neoplasm	0.000113	0.000712	CcSEcCtD
Nicardipine—Chest pain—Doxorubicin—peripheral nervous system neoplasm	0.000113	0.000712	CcSEcCtD
Nicardipine—Anxiety—Doxorubicin—peripheral nervous system neoplasm	0.000112	0.000709	CcSEcCtD
Nicardipine—Discomfort—Doxorubicin—peripheral nervous system neoplasm	0.000111	0.000703	CcSEcCtD
Nicardipine—Dry mouth—Doxorubicin—peripheral nervous system neoplasm	0.00011	0.000696	CcSEcCtD
Nicardipine—Hypotension—Epirubicin—peripheral nervous system neoplasm	0.000109	0.000689	CcSEcCtD
Nicardipine—Confusional state—Doxorubicin—peripheral nervous system neoplasm	0.000109	0.000688	CcSEcCtD
Nicardipine—Oedema—Doxorubicin—peripheral nervous system neoplasm	0.000108	0.000682	CcSEcCtD
Nicardipine—Infection—Doxorubicin—peripheral nervous system neoplasm	0.000107	0.000678	CcSEcCtD
Nicardipine—Musculoskeletal discomfort—Epirubicin—peripheral nervous system neoplasm	0.000106	0.000672	CcSEcCtD
Nicardipine—Shock—Doxorubicin—peripheral nervous system neoplasm	0.000106	0.000671	CcSEcCtD
Nicardipine—Thrombocytopenia—Doxorubicin—peripheral nervous system neoplasm	0.000106	0.000668	CcSEcCtD
Nicardipine—Insomnia—Epirubicin—peripheral nervous system neoplasm	0.000105	0.000667	CcSEcCtD
Nicardipine—Tachycardia—Doxorubicin—peripheral nervous system neoplasm	0.000105	0.000666	CcSEcCtD
Nicardipine—Paraesthesia—Epirubicin—peripheral nervous system neoplasm	0.000105	0.000662	CcSEcCtD
Nicardipine—Hyperhidrosis—Doxorubicin—peripheral nervous system neoplasm	0.000104	0.00066	CcSEcCtD
Nicardipine—Dyspnoea—Epirubicin—peripheral nervous system neoplasm	0.000104	0.000657	CcSEcCtD
Nicardipine—Somnolence—Epirubicin—peripheral nervous system neoplasm	0.000104	0.000655	CcSEcCtD
Nicardipine—Dyspepsia—Epirubicin—peripheral nervous system neoplasm	0.000103	0.000649	CcSEcCtD
Nicardipine—Hypotension—Doxorubicin—peripheral nervous system neoplasm	0.000101	0.000637	CcSEcCtD
Nicardipine—ABCB1—cerebellum—peripheral nervous system neoplasm	9.98e-05	0.00215	CbGeAlD
Nicardipine—Pain—Epirubicin—peripheral nervous system neoplasm	9.97e-05	0.000631	CcSEcCtD
Nicardipine—Constipation—Epirubicin—peripheral nervous system neoplasm	9.97e-05	0.000631	CcSEcCtD
Nicardipine—Musculoskeletal discomfort—Doxorubicin—peripheral nervous system neoplasm	9.83e-05	0.000622	CcSEcCtD
Nicardipine—Insomnia—Doxorubicin—peripheral nervous system neoplasm	9.76e-05	0.000617	CcSEcCtD
Nicardipine—Paraesthesia—Doxorubicin—peripheral nervous system neoplasm	9.69e-05	0.000613	CcSEcCtD
Nicardipine—Dyspnoea—Doxorubicin—peripheral nervous system neoplasm	9.62e-05	0.000608	CcSEcCtD
Nicardipine—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	9.61e-05	0.000608	CcSEcCtD
Nicardipine—Somnolence—Doxorubicin—peripheral nervous system neoplasm	9.59e-05	0.000606	CcSEcCtD
Nicardipine—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	9.53e-05	0.000603	CcSEcCtD
Nicardipine—Dyspepsia—Doxorubicin—peripheral nervous system neoplasm	9.5e-05	0.000601	CcSEcCtD
Nicardipine—Pain—Doxorubicin—peripheral nervous system neoplasm	9.22e-05	0.000583	CcSEcCtD
Nicardipine—Constipation—Doxorubicin—peripheral nervous system neoplasm	9.22e-05	0.000583	CcSEcCtD
Nicardipine—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	9.22e-05	0.000583	CcSEcCtD
Nicardipine—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	9.22e-05	0.000583	CcSEcCtD
Nicardipine—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	8.89e-05	0.000562	CcSEcCtD
Nicardipine—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	8.82e-05	0.000558	CcSEcCtD
Nicardipine—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	8.59e-05	0.000543	CcSEcCtD
Nicardipine—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	8.53e-05	0.000539	CcSEcCtD
Nicardipine—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	8.53e-05	0.000539	CcSEcCtD
Nicardipine—Asthenia—Epirubicin—peripheral nervous system neoplasm	8.36e-05	0.000529	CcSEcCtD
Nicardipine—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	7.98e-05	0.000504	CcSEcCtD
Nicardipine—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	7.95e-05	0.000503	CcSEcCtD
Nicardipine—Asthenia—Doxorubicin—peripheral nervous system neoplasm	7.74e-05	0.000489	CcSEcCtD
Nicardipine—Dizziness—Epirubicin—peripheral nervous system neoplasm	7.71e-05	0.000488	CcSEcCtD
Nicardipine—Vomiting—Epirubicin—peripheral nervous system neoplasm	7.41e-05	0.000469	CcSEcCtD
Nicardipine—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	7.38e-05	0.000467	CcSEcCtD
Nicardipine—Rash—Epirubicin—peripheral nervous system neoplasm	7.35e-05	0.000465	CcSEcCtD
Nicardipine—Dermatitis—Epirubicin—peripheral nervous system neoplasm	7.34e-05	0.000464	CcSEcCtD
Nicardipine—Headache—Epirubicin—peripheral nervous system neoplasm	7.3e-05	0.000462	CcSEcCtD
Nicardipine—Dizziness—Doxorubicin—peripheral nervous system neoplasm	7.13e-05	0.000451	CcSEcCtD
Nicardipine—Nausea—Epirubicin—peripheral nervous system neoplasm	6.92e-05	0.000438	CcSEcCtD
Nicardipine—Vomiting—Doxorubicin—peripheral nervous system neoplasm	6.86e-05	0.000434	CcSEcCtD
Nicardipine—Rash—Doxorubicin—peripheral nervous system neoplasm	6.8e-05	0.00043	CcSEcCtD
Nicardipine—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	6.79e-05	0.00043	CcSEcCtD
Nicardipine—Headache—Doxorubicin—peripheral nervous system neoplasm	6.76e-05	0.000427	CcSEcCtD
Nicardipine—Nausea—Doxorubicin—peripheral nervous system neoplasm	6.41e-05	0.000405	CcSEcCtD
Nicardipine—CYP2C19—Metabolism—TH—peripheral nervous system neoplasm	1.04e-05	9.44e-05	CbGpPWpGaD
Nicardipine—CALM2—Metabolism—ABCB1—peripheral nervous system neoplasm	1.04e-05	9.42e-05	CbGpPWpGaD
Nicardipine—CALM1—Metabolism—ABCB1—peripheral nervous system neoplasm	1.04e-05	9.42e-05	CbGpPWpGaD
Nicardipine—ADRA1D—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	1.04e-05	9.39e-05	CbGpPWpGaD
Nicardipine—ABCB1—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.03e-05	9.35e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling by Wnt—AKT1—peripheral nervous system neoplasm	1.03e-05	9.29e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling by Wnt—AKT1—peripheral nervous system neoplasm	1.03e-05	9.29e-05	CbGpPWpGaD
Nicardipine—CYP2D6—Metabolism—BCHE—peripheral nervous system neoplasm	1.02e-05	9.23e-05	CbGpPWpGaD
Nicardipine—ADRA1D—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	1.02e-05	9.22e-05	CbGpPWpGaD
Nicardipine—ABCB1—Metabolism—TH—peripheral nervous system neoplasm	1.02e-05	9.21e-05	CbGpPWpGaD
Nicardipine—CALM3—Innate Immune System—NRAS—peripheral nervous system neoplasm	1.02e-05	9.21e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—KNG1—peripheral nervous system neoplasm	1.02e-05	9.18e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—KNG1—peripheral nervous system neoplasm	1.02e-05	9.18e-05	CbGpPWpGaD
Nicardipine—CYP2C9—Metabolism—BCHE—peripheral nervous system neoplasm	1.01e-05	9.15e-05	CbGpPWpGaD
Nicardipine—PDE1B—Disease—HRAS—peripheral nervous system neoplasm	1.01e-05	9.13e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	1e-05	9.04e-05	CbGpPWpGaD
Nicardipine—CALM3—Immune System—PTPN11—peripheral nervous system neoplasm	9.87e-06	8.92e-05	CbGpPWpGaD
Nicardipine—CALM1—Innate Immune System—NRAS—peripheral nervous system neoplasm	9.86e-06	8.9e-05	CbGpPWpGaD
Nicardipine—CALM2—Innate Immune System—NRAS—peripheral nervous system neoplasm	9.86e-06	8.9e-05	CbGpPWpGaD
Nicardipine—PDE1A—Signaling Pathways—MYC—peripheral nervous system neoplasm	9.86e-06	8.9e-05	CbGpPWpGaD
Nicardipine—CALM3—Adaptive Immune System—NRAS—peripheral nervous system neoplasm	9.78e-06	8.84e-05	CbGpPWpGaD
Nicardipine—PDE1A—Disease—AKT1—peripheral nervous system neoplasm	9.76e-06	8.82e-05	CbGpPWpGaD
Nicardipine—CYP2D6—Metabolism—SLC2A1—peripheral nervous system neoplasm	9.75e-06	8.81e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	9.68e-06	8.75e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	9.68e-06	8.75e-05	CbGpPWpGaD
Nicardipine—PDE1B—Signaling Pathways—NRAS—peripheral nervous system neoplasm	9.68e-06	8.74e-05	CbGpPWpGaD
Nicardipine—PDE1B—Immune System—AKT1—peripheral nervous system neoplasm	9.67e-06	8.74e-05	CbGpPWpGaD
Nicardipine—CYP2C9—Metabolism—SLC2A1—peripheral nervous system neoplasm	9.66e-06	8.73e-05	CbGpPWpGaD
Nicardipine—CYP2D6—Metabolism—TH—peripheral nervous system neoplasm	9.61e-06	8.68e-05	CbGpPWpGaD
Nicardipine—CYP2C8—Metabolism—GNAS—peripheral nervous system neoplasm	9.55e-06	8.63e-05	CbGpPWpGaD
Nicardipine—CALM2—Immune System—PTPN11—peripheral nervous system neoplasm	9.55e-06	8.63e-05	CbGpPWpGaD
Nicardipine—CALM1—Immune System—PTPN11—peripheral nervous system neoplasm	9.55e-06	8.63e-05	CbGpPWpGaD
Nicardipine—CYP2C9—Metabolism—TH—peripheral nervous system neoplasm	9.52e-06	8.6e-05	CbGpPWpGaD
Nicardipine—CALM1—Adaptive Immune System—NRAS—peripheral nervous system neoplasm	9.46e-06	8.55e-05	CbGpPWpGaD
Nicardipine—CALM2—Adaptive Immune System—NRAS—peripheral nervous system neoplasm	9.46e-06	8.55e-05	CbGpPWpGaD
Nicardipine—CYP2C8—Metabolism—ABCB1—peripheral nervous system neoplasm	9.37e-06	8.47e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—GNAS—peripheral nervous system neoplasm	9.18e-06	8.3e-05	CbGpPWpGaD
Nicardipine—CALM3—Disease—PTPN11—peripheral nervous system neoplasm	9.11e-06	8.23e-05	CbGpPWpGaD
Nicardipine—PDE1B—Signaling Pathways—MYC—peripheral nervous system neoplasm	9.01e-06	8.14e-05	CbGpPWpGaD
Nicardipine—CHRM4—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	8.96e-06	8.1e-05	CbGpPWpGaD
Nicardipine—PDE1B—Disease—AKT1—peripheral nervous system neoplasm	8.93e-06	8.07e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—GNAS—peripheral nervous system neoplasm	8.88e-06	8.02e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—GNAS—peripheral nervous system neoplasm	8.88e-06	8.02e-05	CbGpPWpGaD
Nicardipine—CALM1—Disease—PTPN11—peripheral nervous system neoplasm	8.81e-06	7.96e-05	CbGpPWpGaD
Nicardipine—CALM2—Disease—PTPN11—peripheral nervous system neoplasm	8.81e-06	7.96e-05	CbGpPWpGaD
Nicardipine—CALM3—Hemostasis—TP53—peripheral nervous system neoplasm	8.66e-06	7.82e-05	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	8.62e-06	7.79e-05	CbGpPWpGaD
Nicardipine—CHRM5—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	8.58e-06	7.75e-05	CbGpPWpGaD
Nicardipine—CYP2C19—Metabolism—GNAS—peripheral nervous system neoplasm	8.53e-06	7.7e-05	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	8.47e-06	7.66e-05	CbGpPWpGaD
Nicardipine—CHRM4—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	8.44e-06	7.63e-05	CbGpPWpGaD
Nicardipine—CALM2—Hemostasis—TP53—peripheral nervous system neoplasm	8.37e-06	7.57e-05	CbGpPWpGaD
Nicardipine—CALM1—Hemostasis—TP53—peripheral nervous system neoplasm	8.37e-06	7.57e-05	CbGpPWpGaD
Nicardipine—CYP2C19—Metabolism—ABCB1—peripheral nervous system neoplasm	8.37e-06	7.56e-05	CbGpPWpGaD
Nicardipine—ABCB1—Metabolism—GNAS—peripheral nervous system neoplasm	8.32e-06	7.52e-05	CbGpPWpGaD
Nicardipine—CALM3—Hemostasis—HRAS—peripheral nervous system neoplasm	8.28e-06	7.48e-05	CbGpPWpGaD
Nicardipine—CHRM4—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	8.21e-06	7.42e-05	CbGpPWpGaD
Nicardipine—CHRM4—Signaling Pathways—CASP3—peripheral nervous system neoplasm	8.13e-06	7.35e-05	CbGpPWpGaD
Nicardipine—PDE1A—Signaling Pathways—TP53—peripheral nervous system neoplasm	8.09e-06	7.31e-05	CbGpPWpGaD
Nicardipine—CHRM5—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	8.09e-06	7.31e-05	CbGpPWpGaD
Nicardipine—CACNB2—Metabolism—AKT1—peripheral nervous system neoplasm	8.08e-06	7.3e-05	CbGpPWpGaD
Nicardipine—ADRA1D—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	8.07e-06	7.29e-05	CbGpPWpGaD
Nicardipine—CALM2—Hemostasis—HRAS—peripheral nervous system neoplasm	8.01e-06	7.24e-05	CbGpPWpGaD
Nicardipine—CALM1—Hemostasis—HRAS—peripheral nervous system neoplasm	8.01e-06	7.24e-05	CbGpPWpGaD
Nicardipine—CYP3A4—Metabolism—ENO2—peripheral nervous system neoplasm	7.91e-06	7.14e-05	CbGpPWpGaD
Nicardipine—CHRM5—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	7.86e-06	7.1e-05	CbGpPWpGaD
Nicardipine—CYP2D6—Metabolism—GNAS—peripheral nervous system neoplasm	7.84e-06	7.09e-05	CbGpPWpGaD
Nicardipine—CALM3—Immune System—ERBB2—peripheral nervous system neoplasm	7.8e-06	7.05e-05	CbGpPWpGaD
Nicardipine—CHRM5—Signaling Pathways—CASP3—peripheral nervous system neoplasm	7.79e-06	7.04e-05	CbGpPWpGaD
Nicardipine—CHRM1—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	7.78e-06	7.03e-05	CbGpPWpGaD
Nicardipine—CYP2C9—Metabolism—GNAS—peripheral nervous system neoplasm	7.77e-06	7.02e-05	CbGpPWpGaD
Nicardipine—CHRM3—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	7.76e-06	7.01e-05	CbGpPWpGaD
Nicardipine—PDE1A—Signaling Pathways—HRAS—peripheral nervous system neoplasm	7.74e-06	6.99e-05	CbGpPWpGaD
Nicardipine—CYP2D6—Metabolism—ABCB1—peripheral nervous system neoplasm	7.7e-06	6.95e-05	CbGpPWpGaD
Nicardipine—CHRM2—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	7.68e-06	6.94e-05	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	7.66e-06	6.92e-05	CbGpPWpGaD
Nicardipine—CACNA1D—Metabolism—AKT1—peripheral nervous system neoplasm	7.65e-06	6.92e-05	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	7.65e-06	6.91e-05	CbGpPWpGaD
Nicardipine—CYP2C9—Metabolism—ABCB1—peripheral nervous system neoplasm	7.63e-06	6.89e-05	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	7.62e-06	6.89e-05	CbGpPWpGaD
Nicardipine—ADRA1D—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	7.6e-06	6.87e-05	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	7.55e-06	6.82e-05	CbGpPWpGaD
Nicardipine—CALM2—Immune System—ERBB2—peripheral nervous system neoplasm	7.55e-06	6.82e-05	CbGpPWpGaD
Nicardipine—CALM1—Immune System—ERBB2—peripheral nervous system neoplasm	7.55e-06	6.82e-05	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	7.53e-06	6.8e-05	CbGpPWpGaD
Nicardipine—CHRM4—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	7.46e-06	6.74e-05	CbGpPWpGaD
Nicardipine—CALM3—Innate Immune System—HRAS—peripheral nervous system neoplasm	7.45e-06	6.73e-05	CbGpPWpGaD
Nicardipine—PDE1B—Signaling Pathways—TP53—peripheral nervous system neoplasm	7.4e-06	6.69e-05	CbGpPWpGaD
Nicardipine—ADRA1D—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	7.39e-06	6.68e-05	CbGpPWpGaD
Nicardipine—ADRA1D—Signaling Pathways—CASP3—peripheral nervous system neoplasm	7.32e-06	6.62e-05	CbGpPWpGaD
Nicardipine—CALM3—Hemostasis—AKT1—peripheral nervous system neoplasm	7.31e-06	6.6e-05	CbGpPWpGaD
Nicardipine—CALM2—Innate Immune System—HRAS—peripheral nervous system neoplasm	7.21e-06	6.51e-05	CbGpPWpGaD
Nicardipine—CALM1—Innate Immune System—HRAS—peripheral nervous system neoplasm	7.21e-06	6.51e-05	CbGpPWpGaD
Nicardipine—CALM3—Disease—ERBB2—peripheral nervous system neoplasm	7.2e-06	6.51e-05	CbGpPWpGaD
Nicardipine—CALM3—Adaptive Immune System—HRAS—peripheral nervous system neoplasm	7.16e-06	6.47e-05	CbGpPWpGaD
Nicardipine—CHRM5—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	7.14e-06	6.45e-05	CbGpPWpGaD
Nicardipine—PDE1B—Signaling Pathways—HRAS—peripheral nervous system neoplasm	7.08e-06	6.4e-05	CbGpPWpGaD
Nicardipine—CALM1—Hemostasis—AKT1—peripheral nervous system neoplasm	7.07e-06	6.39e-05	CbGpPWpGaD
Nicardipine—CALM2—Hemostasis—AKT1—peripheral nervous system neoplasm	7.07e-06	6.39e-05	CbGpPWpGaD
Nicardipine—CALM1—Disease—ERBB2—peripheral nervous system neoplasm	6.97e-06	6.29e-05	CbGpPWpGaD
Nicardipine—CALM2—Disease—ERBB2—peripheral nervous system neoplasm	6.97e-06	6.29e-05	CbGpPWpGaD
Nicardipine—CALM2—Adaptive Immune System—HRAS—peripheral nervous system neoplasm	6.92e-06	6.26e-05	CbGpPWpGaD
Nicardipine—CALM1—Adaptive Immune System—HRAS—peripheral nervous system neoplasm	6.92e-06	6.26e-05	CbGpPWpGaD
Nicardipine—PDE1A—Signaling Pathways—AKT1—peripheral nervous system neoplasm	6.83e-06	6.17e-05	CbGpPWpGaD
Nicardipine—CHRM4—Signaling Pathways—NRAS—peripheral nervous system neoplasm	6.82e-06	6.16e-05	CbGpPWpGaD
Nicardipine—CACNA1C—Metabolism—AKT1—peripheral nervous system neoplasm	6.72e-06	6.08e-05	CbGpPWpGaD
Nicardipine—ADRA1D—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	6.71e-06	6.06e-05	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	6.7e-06	6.05e-05	CbGpPWpGaD
Nicardipine—CYP3A4—Metabolism—BCHE—peripheral nervous system neoplasm	6.68e-06	6.04e-05	CbGpPWpGaD
Nicardipine—CALM3—Innate Immune System—AKT1—peripheral nervous system neoplasm	6.58e-06	5.95e-05	CbGpPWpGaD
Nicardipine—CHRM5—Signaling Pathways—NRAS—peripheral nervous system neoplasm	6.53e-06	5.9e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	6.49e-06	5.87e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	6.38e-06	5.77e-05	CbGpPWpGaD
Nicardipine—CYP3A4—Metabolism—SLC2A1—peripheral nervous system neoplasm	6.37e-06	5.76e-05	CbGpPWpGaD
Nicardipine—CALM2—Innate Immune System—AKT1—peripheral nervous system neoplasm	6.37e-06	5.75e-05	CbGpPWpGaD
Nicardipine—CALM1—Innate Immune System—AKT1—peripheral nervous system neoplasm	6.37e-06	5.75e-05	CbGpPWpGaD
Nicardipine—CHRM4—Signaling Pathways—MYC—peripheral nervous system neoplasm	6.35e-06	5.74e-05	CbGpPWpGaD
Nicardipine—CALM3—Adaptive Immune System—AKT1—peripheral nervous system neoplasm	6.32e-06	5.71e-05	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	6.31e-06	5.7e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	6.28e-06	5.68e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	6.28e-06	5.68e-05	CbGpPWpGaD
Nicardipine—CYP3A4—Metabolism—TH—peripheral nervous system neoplasm	6.28e-06	5.67e-05	CbGpPWpGaD
Nicardipine—PDE1B—Signaling Pathways—AKT1—peripheral nervous system neoplasm	6.25e-06	5.65e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	6.17e-06	5.58e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	6.17e-06	5.58e-05	CbGpPWpGaD
Nicardipine—ADRA1D—Signaling Pathways—NRAS—peripheral nervous system neoplasm	6.14e-06	5.55e-05	CbGpPWpGaD
Nicardipine—ADRA1B—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	6.14e-06	5.54e-05	CbGpPWpGaD
Nicardipine—CALM2—Adaptive Immune System—AKT1—peripheral nervous system neoplasm	6.11e-06	5.52e-05	CbGpPWpGaD
Nicardipine—CALM1—Adaptive Immune System—AKT1—peripheral nervous system neoplasm	6.11e-06	5.52e-05	CbGpPWpGaD
Nicardipine—CHRM5—Signaling Pathways—MYC—peripheral nervous system neoplasm	6.08e-06	5.49e-05	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling Pathways—CASP3—peripheral nervous system neoplasm	6.08e-06	5.49e-05	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	6.04e-06	5.46e-05	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	6.02e-06	5.44e-05	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	5.96e-06	5.39e-05	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	5.95e-06	5.37e-05	CbGpPWpGaD
Nicardipine—CALM3—Immune System—NRAS—peripheral nervous system neoplasm	5.93e-06	5.36e-05	CbGpPWpGaD
Nicardipine—CALM2—Immune System—NRAS—peripheral nervous system neoplasm	5.74e-06	5.19e-05	CbGpPWpGaD
Nicardipine—CALM1—Immune System—NRAS—peripheral nervous system neoplasm	5.74e-06	5.19e-05	CbGpPWpGaD
Nicardipine—ADRA1D—Signaling Pathways—MYC—peripheral nervous system neoplasm	5.72e-06	5.17e-05	CbGpPWpGaD
Nicardipine—CHRM1—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	5.69e-06	5.14e-05	CbGpPWpGaD
Nicardipine—CHRM3—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	5.68e-06	5.13e-05	CbGpPWpGaD
Nicardipine—CHRM2—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	5.62e-06	5.08e-05	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	5.6e-06	5.06e-05	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	5.57e-06	5.03e-05	CbGpPWpGaD
Nicardipine—CHRM1—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	5.54e-06	5e-05	CbGpPWpGaD
Nicardipine—CHRM3—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	5.52e-06	4.99e-05	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—CASP3—peripheral nervous system neoplasm	5.48e-06	4.96e-05	CbGpPWpGaD
Nicardipine—CALM3—Disease—NRAS—peripheral nervous system neoplasm	5.48e-06	4.95e-05	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—CASP3—peripheral nervous system neoplasm	5.47e-06	4.94e-05	CbGpPWpGaD
Nicardipine—CHRM2—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	5.46e-06	4.94e-05	CbGpPWpGaD
Nicardipine—ADRA1A—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	5.45e-06	4.92e-05	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—CASP3—peripheral nervous system neoplasm	5.41e-06	4.89e-05	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—CASP3—peripheral nervous system neoplasm	5.4e-06	4.88e-05	CbGpPWpGaD
Nicardipine—CALM2—Disease—NRAS—peripheral nervous system neoplasm	5.3e-06	4.79e-05	CbGpPWpGaD
Nicardipine—CALM1—Disease—NRAS—peripheral nervous system neoplasm	5.3e-06	4.79e-05	CbGpPWpGaD
Nicardipine—CHRM4—Signaling Pathways—TP53—peripheral nervous system neoplasm	5.22e-06	4.71e-05	CbGpPWpGaD
Nicardipine—CYP3A4—Metabolism—GNAS—peripheral nervous system neoplasm	5.13e-06	4.63e-05	CbGpPWpGaD
Nicardipine—CALM3—Disease—MYC—peripheral nervous system neoplasm	5.1e-06	4.61e-05	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling Pathways—NRAS—peripheral nervous system neoplasm	5.09e-06	4.6e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	5.04e-06	4.56e-05	CbGpPWpGaD
Nicardipine—CYP3A4—Metabolism—ABCB1—peripheral nervous system neoplasm	5.03e-06	4.55e-05	CbGpPWpGaD
Nicardipine—CHRM1—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	5.03e-06	4.54e-05	CbGpPWpGaD
Nicardipine—CHRM3—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	5.01e-06	4.53e-05	CbGpPWpGaD
Nicardipine—CHRM5—Signaling Pathways—TP53—peripheral nervous system neoplasm	4.99e-06	4.51e-05	CbGpPWpGaD
Nicardipine—CHRM4—Signaling Pathways—HRAS—peripheral nervous system neoplasm	4.99e-06	4.51e-05	CbGpPWpGaD
Nicardipine—CHRM2—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	4.96e-06	4.48e-05	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	4.95e-06	4.47e-05	CbGpPWpGaD
Nicardipine—CALM1—Disease—MYC—peripheral nervous system neoplasm	4.94e-06	4.46e-05	CbGpPWpGaD
Nicardipine—CALM2—Disease—MYC—peripheral nervous system neoplasm	4.94e-06	4.46e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	4.88e-06	4.41e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	4.88e-06	4.41e-05	CbGpPWpGaD
Nicardipine—CHRM5—Signaling Pathways—HRAS—peripheral nervous system neoplasm	4.78e-06	4.32e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	4.75e-06	4.29e-05	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling Pathways—MYC—peripheral nervous system neoplasm	4.75e-06	4.29e-05	CbGpPWpGaD
Nicardipine—ADRA1D—Signaling Pathways—TP53—peripheral nervous system neoplasm	4.7e-06	4.24e-05	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—NRAS—peripheral nervous system neoplasm	4.6e-06	4.15e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	4.6e-06	4.15e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	4.6e-06	4.15e-05	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—NRAS—peripheral nervous system neoplasm	4.58e-06	4.14e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—CASP3—peripheral nervous system neoplasm	4.58e-06	4.14e-05	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—NRAS—peripheral nervous system neoplasm	4.54e-06	4.1e-05	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—NRAS—peripheral nervous system neoplasm	4.53e-06	4.09e-05	CbGpPWpGaD
Nicardipine—ADRA1D—Signaling Pathways—HRAS—peripheral nervous system neoplasm	4.49e-06	4.06e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—CASP3—peripheral nervous system neoplasm	4.43e-06	4e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—CASP3—peripheral nervous system neoplasm	4.43e-06	4e-05	CbGpPWpGaD
Nicardipine—CHRM4—Signaling Pathways—AKT1—peripheral nervous system neoplasm	4.4e-06	3.98e-05	CbGpPWpGaD
Nicardipine—CALM3—Immune System—HRAS—peripheral nervous system neoplasm	4.34e-06	3.92e-05	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—MYC—peripheral nervous system neoplasm	4.28e-06	3.87e-05	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—MYC—peripheral nervous system neoplasm	4.27e-06	3.86e-05	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—MYC—peripheral nervous system neoplasm	4.23e-06	3.82e-05	CbGpPWpGaD
Nicardipine—CHRM5—Signaling Pathways—AKT1—peripheral nervous system neoplasm	4.22e-06	3.81e-05	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—MYC—peripheral nervous system neoplasm	4.22e-06	3.81e-05	CbGpPWpGaD
Nicardipine—CALM2—Immune System—HRAS—peripheral nervous system neoplasm	4.2e-06	3.79e-05	CbGpPWpGaD
Nicardipine—CALM1—Immune System—HRAS—peripheral nervous system neoplasm	4.2e-06	3.79e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	4.2e-06	3.79e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	4.06e-06	3.67e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	4.06e-06	3.67e-05	CbGpPWpGaD
Nicardipine—CALM3—Disease—HRAS—peripheral nervous system neoplasm	4.01e-06	3.62e-05	CbGpPWpGaD
Nicardipine—ADRA1D—Signaling Pathways—AKT1—peripheral nervous system neoplasm	3.97e-06	3.58e-05	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling Pathways—TP53—peripheral nervous system neoplasm	3.9e-06	3.52e-05	CbGpPWpGaD
Nicardipine—CALM2—Disease—HRAS—peripheral nervous system neoplasm	3.88e-06	3.5e-05	CbGpPWpGaD
Nicardipine—CALM1—Disease—HRAS—peripheral nervous system neoplasm	3.88e-06	3.5e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—NRAS—peripheral nervous system neoplasm	3.84e-06	3.47e-05	CbGpPWpGaD
Nicardipine—CALM3—Immune System—AKT1—peripheral nervous system neoplasm	3.83e-06	3.46e-05	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling Pathways—HRAS—peripheral nervous system neoplasm	3.73e-06	3.37e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—NRAS—peripheral nervous system neoplasm	3.71e-06	3.35e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—NRAS—peripheral nervous system neoplasm	3.71e-06	3.35e-05	CbGpPWpGaD
Nicardipine—CALM1—Immune System—AKT1—peripheral nervous system neoplasm	3.71e-06	3.35e-05	CbGpPWpGaD
Nicardipine—CALM2—Immune System—AKT1—peripheral nervous system neoplasm	3.71e-06	3.35e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—MYC—peripheral nervous system neoplasm	3.57e-06	3.23e-05	CbGpPWpGaD
Nicardipine—CHRM3—Metabolism—AKT1—peripheral nervous system neoplasm	3.54e-06	3.2e-05	CbGpPWpGaD
Nicardipine—CALM3—Disease—AKT1—peripheral nervous system neoplasm	3.54e-06	3.2e-05	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—TP53—peripheral nervous system neoplasm	3.52e-06	3.18e-05	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—TP53—peripheral nervous system neoplasm	3.51e-06	3.17e-05	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—TP53—peripheral nervous system neoplasm	3.47e-06	3.14e-05	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—TP53—peripheral nervous system neoplasm	3.46e-06	3.13e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—MYC—peripheral nervous system neoplasm	3.46e-06	3.12e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—MYC—peripheral nervous system neoplasm	3.46e-06	3.12e-05	CbGpPWpGaD
Nicardipine—CALM1—Disease—AKT1—peripheral nervous system neoplasm	3.42e-06	3.09e-05	CbGpPWpGaD
Nicardipine—CALM2—Disease—AKT1—peripheral nervous system neoplasm	3.42e-06	3.09e-05	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—HRAS—peripheral nervous system neoplasm	3.36e-06	3.04e-05	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—HRAS—peripheral nervous system neoplasm	3.35e-06	3.03e-05	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—HRAS—peripheral nervous system neoplasm	3.32e-06	3e-05	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—HRAS—peripheral nervous system neoplasm	3.31e-06	2.99e-05	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling Pathways—AKT1—peripheral nervous system neoplasm	3.29e-06	2.97e-05	CbGpPWpGaD
Nicardipine—CYP2B6—Metabolism—AKT1—peripheral nervous system neoplasm	3.05e-06	2.75e-05	CbGpPWpGaD
Nicardipine—CYP2E1—Metabolism—AKT1—peripheral nervous system neoplasm	2.98e-06	2.7e-05	CbGpPWpGaD
Nicardipine—CYP3A5—Metabolism—AKT1—peripheral nervous system neoplasm	2.98e-06	2.69e-05	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—AKT1—peripheral nervous system neoplasm	2.97e-06	2.68e-05	CbGpPWpGaD
Nicardipine—CALM3—Metabolism—AKT1—peripheral nervous system neoplasm	2.96e-06	2.68e-05	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—AKT1—peripheral nervous system neoplasm	2.96e-06	2.67e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—TP53—peripheral nervous system neoplasm	2.93e-06	2.65e-05	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—AKT1—peripheral nervous system neoplasm	2.93e-06	2.65e-05	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—AKT1—peripheral nervous system neoplasm	2.92e-06	2.64e-05	CbGpPWpGaD
Nicardipine—CALM2—Metabolism—AKT1—peripheral nervous system neoplasm	2.87e-06	2.59e-05	CbGpPWpGaD
Nicardipine—CALM1—Metabolism—AKT1—peripheral nervous system neoplasm	2.87e-06	2.59e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—TP53—peripheral nervous system neoplasm	2.84e-06	2.57e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—TP53—peripheral nervous system neoplasm	2.84e-06	2.57e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—HRAS—peripheral nervous system neoplasm	2.81e-06	2.54e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—HRAS—peripheral nervous system neoplasm	2.72e-06	2.45e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—HRAS—peripheral nervous system neoplasm	2.72e-06	2.45e-05	CbGpPWpGaD
Nicardipine—CYP2C8—Metabolism—AKT1—peripheral nervous system neoplasm	2.58e-06	2.33e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—AKT1—peripheral nervous system neoplasm	2.48e-06	2.24e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—AKT1—peripheral nervous system neoplasm	2.4e-06	2.17e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—AKT1—peripheral nervous system neoplasm	2.4e-06	2.17e-05	CbGpPWpGaD
Nicardipine—CYP2C19—Metabolism—AKT1—peripheral nervous system neoplasm	2.3e-06	2.08e-05	CbGpPWpGaD
Nicardipine—ABCB1—Metabolism—AKT1—peripheral nervous system neoplasm	2.25e-06	2.03e-05	CbGpPWpGaD
Nicardipine—CYP2D6—Metabolism—AKT1—peripheral nervous system neoplasm	2.12e-06	1.91e-05	CbGpPWpGaD
Nicardipine—CYP2C9—Metabolism—AKT1—peripheral nervous system neoplasm	2.1e-06	1.9e-05	CbGpPWpGaD
Nicardipine—CYP3A4—Metabolism—AKT1—peripheral nervous system neoplasm	1.38e-06	1.25e-05	CbGpPWpGaD
